GlassScriptPhysician profile
Kenneth A Berger
NPI 1366407942
$9,247.80
in general payments reported to CMS, 2019-2025
36 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,126 · 2020: $20.33 · 2021: $384 · 2022: $1,041 · 2023: $897 · 2024: $1,018 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,478 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,478.17 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,809.16 | 2019-2022 | |
| Astellas Pharma US INC | $649.21 | 2019-2025 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $571.77 | 2023-2025 | Gemtesa, Orgovyx |
| Cook Medical LLC | $356.63 | 2024-2025 | Litho 150, Cook |
| Progenics Pharmaceuticals, INC. | $322.02 | 2022-2024 | Pylarify |
| Abbvie INC. | $304.43 | 2019-2025 | Botox |
| Boston Scientific Corporation | $299.09 | 2019-2025 | Lithovue, Rezum Generator |
| Janssen Biotech, INC. | $271.26 | 2022-2025 | Erleada |
| Astrazeneca Pharmaceuticals LP | $227.46 | 2021-2025 | |
| Pfizer INC. | $194.80 | 2022-2025 | |
| Urovant Sciences INC | $136.29 | 2022 | |
| Dendreon Pharmaceuticals LLC | $119.60 | 2019-2025 | Provenge |
| Olympus America INC. | $98.79 | 2021 | |
| Procept Biorobotics Corporation | $96.22 | 2024 | Aquabeam System |
| 180 Medical, INC. | $86.75 | 2019-2023 | Gentlecath Glide |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $86.45 | 2021-2025 | Prolaris |
| Myovant Sciences INC. | $72.56 | 2021-2022 | |
| Medtronic, INC. | $67.94 | 2024 | Interstim |
| Karl Storz Endoscopy-America | $50.13 | 2021 | |
| Coloplast Corp | $49.35 | 2019-2023 | Speedicath, Altis |
| Merck Sharp & Dohme LLC | $46.64 | 2021-2025 | Lynparza |
| Endo Pharmaceuticals INC. | $45.83 | 2021-2023 | Xiaflex |
| Baxter Healthcare | $42.93 | 2019 | |
| Ambu INC. | $35.21 | 2025 | |
| Allergan, INC. | $26.41 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $21.12 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Ferring Pharmaceuticals INC. | $20.15 | 2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $19.70 | 2023 | |
| Immunitybio, INC. | $19.37 | 2024 | |
| Accord Healthcare, INC. | $18.82 | 2024 | |
| Conmed Corporation | $15.63 | 2024 | Airseal |
| Axonics, INC. | $15.42 | 2023 | Axonics |
| Teleflex LLC | $13.75 | 2023 | Urolift |
| Photocure INC | $12.76 | 2021 | |
| Medtronic USA, INC. | $12.69 | 2020 | |
| Travere Therapeutics, INC. | $11.46 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.